Publications by authors named "Yoshitaka Shirasago"

Claim this Profile
[
[GenAhead Bio: your partner for extensive support of genome editing and co-‍development of nucleic acid delivery].
Tsukasa Sugo, Yoshitaka Shirasago, Shingo Yoshimoto, Miha Kitajima

Nihon Yakurigaku Zasshi· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Proteomics for Identifying the Alteration Pathway of Niemann-Pick Disease Type C Using Hepatic Cell Models.
Keitaro Miyoshi, Eiji Hishinuma, Naomi Matsukawa, Yoshitaka Shirasago, Masahiro Watanabe

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection.
Yoshitaka Shirasago, Hidesuke Fukazawa, Shotaro Nagase, Yoshimi Shimizu, Tomoharu Mizukami

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus.
Motohiko Ogawa, Yoshitaka Shirasago, Isei Tanida, Soichiro Kakuta, Yasuo Uchiyama

J Infect Chemother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occludin-binding single-chain variable fragment and antigen-binding fragment antibodies prevent hepatitis C virus infection.
Yoshimi Shimizu, Takehiro Shinoda, Yoshitaka Shirasago, Masuo Kondoh, Naoko Shinya

FEBS Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Characteristic Genomic Markers in Human Hepatoma HuH-7 and Huh7.5.1-8 Cell Lines.
Masaki Kawamoto, Toshiyuki Yamaji, Kyoko Saito, Yoshitaka Shirasago, Kazuhiro Satomura

Front Genet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero.
Kyoko Saito, Masayoshi Fukasawa, Yoshitaka Shirasago, Ryosuke Suzuki, Naoki Osada

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of monoclonal antibodies recognizing each extracellular loop domain of occludin.
Yoshimi Shimizu, Yoshitaka Shirasago, Takeru Suzuki, Tomoyuki Hata, Masuo Kondoh

J Biochem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid.
Yoshitaka Shirasago, Yoko Inamori, Takeru Suzuki, Isei Tanida, Tetsuro Suzuki

Biol Pharm Bull· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection.
Yoshimi Shimizu, Kohei Yoneda, Yoshitaka Shirasago, Takeru Suzuki, Minoru Tada

Biochem Biophys Res Commun· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro [J Infect Chemother 24 (8) (2018) 597-601].
Motohiko Ogawa, Yoshitaka Shirasago, Shuji Ando, Masayuki Shimojima, Masayuki Saijo

J Infect Chemother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermostable hepatitis C virus JFH1-derived variant isolated by adaptation to Huh7.5.1 cells.
Yoshitaka Shirasago, Hidesuke Fukazawa, Hideki Aizaki, Tetsuro Suzuki, Takeru Suzuki

J Gen Virol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro.
Motohiko Ogawa, Yoshitaka Shirasago, Shuji Ando, Masayuki Shimojima, Masayuki Saijo

J Infect Chemother· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
Yoshimi Shimizu, Yoshitaka Shirasago, Masuo Kondoh, Tetsuro Suzuki, Takaji Wakita

J Virol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus.
Isei Tanida, Yoshitaka Shirasago, Ryosuke Suzuki, Ryo Abe, Takaji Wakita

Jpn J Infect Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection.
Yoshitaka Shirasago, Yoshimi Shimizu, Isei Tanida, Tetsuro Suzuki, Ryosuke Suzuki

Biol Pharm Bull· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus.
Yoshitaka Shirasago, Tsuyoshi Sekizuka, Kyoko Saito, Tetsuro Suzuki, Takaji Wakita

Jpn J Infect Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model.
Misaki Nakajima, Shotaro Nagase, Manami Iida, Shuji Takeda, Mayo Yamashita, Yoshitaka Shirasago

J Pharmacol Exp Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
Masayoshi Fukasawa, Shotaro Nagase, Yoshitaka Shirasago, Manami Iida, Mayo Yamashita

J Virol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus.
Mayo Yamashita, Manami Iida, Minoru Tada, Yoshitaka Shirasago, Masayoshi Fukasawa

J Pharmacol Exp Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Kyoko Saito, Yoshitaka Shirasago, Tetsuro Suzuki, Hideki Aizaki, Kentaro Hanada

J Virol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis